
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Extraglycemic Effect of SGLT-2is on Mineral and Bone Metabolism and Bone Fracture
Bingzi Dong, Ruolin Lv, Jun Wang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 24
Bingzi Dong, Ruolin Lv, Jun Wang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 24
Showing 24 citing articles:
Impact of Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) Therapy on Dementia and Cognitive Decline
Antonio Lardaro, L. Quarta, Stefania Pagnotta, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1750-1750
Open Access | Times Cited: 19
Antonio Lardaro, L. Quarta, Stefania Pagnotta, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1750-1750
Open Access | Times Cited: 19
Cardiovascular-renal protective effect and molecular mechanism of finerenone in type 2 diabetic mellitus
Ruolin Lv, Lili Xu, Lin Che, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 27
Ruolin Lv, Lili Xu, Lin Che, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 27
Geriatric nutritional risk index as a predictor for fragility fracture risk in elderly with type 2 diabetes mellitus: A 9-year ambispective longitudinal cohort study
Jiangmei Pan, Guoling Xu, Zhenwei Zhai, et al.
Clinical Nutrition (2024) Vol. 43, Iss. 5, pp. 1125-1135
Open Access | Times Cited: 12
Jiangmei Pan, Guoling Xu, Zhenwei Zhai, et al.
Clinical Nutrition (2024) Vol. 43, Iss. 5, pp. 1125-1135
Open Access | Times Cited: 12
Lu Zeng, Jie Li, Fanfan Gao, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 6
Open Access | Times Cited: 4
Is the Impact of Sodium–Glucose Co-Transporter 2 (SGLT2) Inhibitors on Bone Metabolism and Fracture Incidence a Class or Drug Effect? A Narrative Review
George Ι. Lambrou, Athanasia Samartzi, Eugenia Vlachou, et al.
Medicines (2025) Vol. 12, Iss. 2, pp. 10-10
Open Access
George Ι. Lambrou, Athanasia Samartzi, Eugenia Vlachou, et al.
Medicines (2025) Vol. 12, Iss. 2, pp. 10-10
Open Access
Mouse Models with SGLT2 Mutations: Toward Understanding the Role of SGLT2 beyond Glucose Reabsorption
Keiko Unno, Kyoko Taguchi, Yoshiichi Takagi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6278-6278
Open Access | Times Cited: 10
Keiko Unno, Kyoko Taguchi, Yoshiichi Takagi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6278-6278
Open Access | Times Cited: 10
SGLT-2 Inhibitors for Non-Alcoholic Fatty Liver Disease: A Review
Rong Xu, Difei Lian, Yan Xie, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 7, pp. 134-134
Open Access | Times Cited: 10
Rong Xu, Difei Lian, Yan Xie, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 7, pp. 134-134
Open Access | Times Cited: 10
Effects of sodium-glucose cotransporter 2 inhibitors on bone metabolism in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
Jing Wang, Xin Li, Yang Li, et al.
BMC Endocrine Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Jing Wang, Xin Li, Yang Li, et al.
BMC Endocrine Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Risk factors for osteoporosis in elderly patients with type 2 diabetes: A protocol for systematic review and meta-analysis
Wenhao Su, Hairong Jia, Yang Luo, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0319602-e0319602
Open Access
Wenhao Su, Hairong Jia, Yang Luo, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0319602-e0319602
Open Access
Evaluation of the Effect of Sodium-Glucose Cotransporter 2 Inhibition on Fracture Risk: Evidence From Mendelian Randomization and Genetic Association Study
Huajie Dai, Longyi Zheng, Zheng Zhu, et al.
Journal of Bone and Mineral Research (2023) Vol. 38, Iss. 11, pp. 1645-1653
Open Access | Times Cited: 9
Huajie Dai, Longyi Zheng, Zheng Zhu, et al.
Journal of Bone and Mineral Research (2023) Vol. 38, Iss. 11, pp. 1645-1653
Open Access | Times Cited: 9
Fracture risks associated with sodium-glucose cotransporter-2 inhibitors in type 2 diabetes patients across eGFR and albuminuria categories: A population-based study in Hong Kong
David Tak Wai Lui, Tingting Wu, Eric Ho Man Tang, et al.
Diabetes Research and Clinical Practice (2023) Vol. 197, pp. 110576-110576
Closed Access | Times Cited: 7
David Tak Wai Lui, Tingting Wu, Eric Ho Man Tang, et al.
Diabetes Research and Clinical Practice (2023) Vol. 197, pp. 110576-110576
Closed Access | Times Cited: 7
Management of Type 2 Diabetes in Frail Older Adults
Gülistan Bahat, Serdar Özkök, Mirko Petrović
Drugs & Aging (2023) Vol. 40, Iss. 9, pp. 751-761
Closed Access | Times Cited: 7
Gülistan Bahat, Serdar Özkök, Mirko Petrović
Drugs & Aging (2023) Vol. 40, Iss. 9, pp. 751-761
Closed Access | Times Cited: 7
Effect of Antidiabetic Drugs on Bone Health in Patients with Normal Renal Function and in Chronic Kidney Disease (CKD): Insight into Clinical Challenges in the Treatment of Type 2 Diabetes
Cristiana Cipriani, Gabriella Lauriero, Giovanni Tripepi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7260-7260
Open Access | Times Cited: 6
Cristiana Cipriani, Gabriella Lauriero, Giovanni Tripepi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7260-7260
Open Access | Times Cited: 6
Enhanced hepatoprotective effects of empagliflozin and vitamin D dual therapy against metabolic dysfunction‐associated steatohepatitis in mice by boosted modulation of metabolic, oxidative stress, and inflammatory pathways
Wesam F. Farrash, Shakir Idris, Mohamed E. Elzubier, et al.
International Journal of Experimental Pathology (2024) Vol. 105, Iss. 6, pp. 219-234
Open Access | Times Cited: 1
Wesam F. Farrash, Shakir Idris, Mohamed E. Elzubier, et al.
International Journal of Experimental Pathology (2024) Vol. 105, Iss. 6, pp. 219-234
Open Access | Times Cited: 1
Association between sarcopenia and the foot-ankle function in type 2 diabetic foot ulcer
Shujing An, Wenjun Kuang, Yue Hu, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Shujing An, Wenjun Kuang, Yue Hu, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus
Abdulrahman Mujalli, Wesam F. Farrash, Ahmad A. Obaid, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17380-17380
Open Access | Times Cited: 3
Abdulrahman Mujalli, Wesam F. Farrash, Ahmad A. Obaid, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17380-17380
Open Access | Times Cited: 3
Progress in the Study of the Hepatoprotective Effect of SGLT2i on NAFLD Patients with T2DM
Fan Yang, Xiaoping Tan
Journal of Biosciences and Medicines (2024) Vol. 12, Iss. 01, pp. 115-125
Open Access
Fan Yang, Xiaoping Tan
Journal of Biosciences and Medicines (2024) Vol. 12, Iss. 01, pp. 115-125
Open Access
Familial renal glycosuria as a genetic model of long-term SGLT2 inhibition: potential implications for calcium phosphate metabolism and bone health
Merita Rroji, Marsida Kasa, Nereida Spahia, et al.
Journal of Nephrology (2024)
Closed Access
Merita Rroji, Marsida Kasa, Nereida Spahia, et al.
Journal of Nephrology (2024)
Closed Access
Estudio del efecto del tratamiento con fármacos antidiabéticos sobre el metabolismo óseo
Nuria Padilla Apuntate, Carmen Gracia Puerto Cabeza, Alba Gallego Royo, et al.
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio (2024) Vol. 5, Iss. 1, pp. 90-95
Open Access
Nuria Padilla Apuntate, Carmen Gracia Puerto Cabeza, Alba Gallego Royo, et al.
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio (2024) Vol. 5, Iss. 1, pp. 90-95
Open Access
Effects of antidiabetic drugs on bone metabolism
Nuria Padilla Apuntate, Carmen Gracia Puerto Cabeza, Alba Gallego Royo, et al.
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio (2024) Vol. 5, Iss. 1, pp. 85-89
Open Access
Nuria Padilla Apuntate, Carmen Gracia Puerto Cabeza, Alba Gallego Royo, et al.
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio (2024) Vol. 5, Iss. 1, pp. 85-89
Open Access
Author’s Reply to Peronard and Mayntz: “SGLT2 Inhibitors, and How They Work Beyond the Glucosuric Effect”
David Aristizábal-Colorado, Martín Ocampo Posada, Wilfredo Antonio Rivera Martínez, et al.
American Journal of Cardiovascular Drugs (2024)
Closed Access
David Aristizábal-Colorado, Martín Ocampo Posada, Wilfredo Antonio Rivera Martínez, et al.
American Journal of Cardiovascular Drugs (2024)
Closed Access
Уровень содержания интерлейкинов в ротовой жидкости при травматических переломах нижней челюсти
И. О. Походенько-Чудакова, Али Тергам Абдуламир Али, Л. В. Картун, et al.
Dentist Minsk (2023), Iss. 1 (48), pp. 32-35
Closed Access
И. О. Походенько-Чудакова, Али Тергам Абдуламир Али, Л. В. Картун, et al.
Dentist Minsk (2023), Iss. 1 (48), pp. 32-35
Closed Access
Effect of sodium-glucose transporter 2 inhibitors on bone
Mahdi Baradaranfard, Taha Ameli
Journal of Parathyroid Disease (2023) Vol. 11, pp. e11225-e11225
Open Access
Mahdi Baradaranfard, Taha Ameli
Journal of Parathyroid Disease (2023) Vol. 11, pp. e11225-e11225
Open Access
SGLT2 Inhibitors Reduce Uric Acid-Related Adverse Events in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Y. T. Shin, J S Park, Ji Hae Kim, et al.
Journal of Korean Society of Health-System Pharmacists (2023) Vol. 40, Iss. 4, pp. 423-432
Open Access
Y. T. Shin, J S Park, Ji Hae Kim, et al.
Journal of Korean Society of Health-System Pharmacists (2023) Vol. 40, Iss. 4, pp. 423-432
Open Access